BRIEF-Aditxt Signs Second Amendment Arrangement Agreement With Appili Therapeutics-March 2024-www.financetom.com

BRIEF-Aditxt Signs Second Amendment Arrangement Agreement With Appili Therapeutics

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Aditxt Signs Second Amendment Arrangement Agreement With Appili Therapeutics

Jul 25, 2024 6:48 AM

July 25 (Reuters) - Aditxt Inc ( ADTX ):

* ADITXT SIGNS SECOND AMENDMENT TO THE ARRANGEMENT AGREEMENT

WITH

APPILI THERAPEUTICS, TARGETING SEPTEMBER 30 CLOSING OF THE

ACQUISITION

Source text for Eikon:

Further company coverage:

Previous page： Domo, Data Consulting Group Collaborate to Improve Business Intelligence Capabilities for Global Companies Next page： Helios Technologies Appoints Sean Bagan as CEO

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Domo, Data Consulting Group Collaborate to Improve Business Intelligence Capabilities for Global Companies

Jan 6, 2025

04:44 PM EST, 01/06/2025 (MT Newswires) -- Domo ( DOMO ) said Monday it is collaborating with Data Consulting Group to offer improved business intelligence capabilities for global companies. Financial details weren't disclosed. Data Consulting Group will integrate Domo's ( DOMO ) AI and data products into its services, providing real-time interactive dashboards and embedded analytics to clients while aiming...

Helios Technologies Appoints Sean Bagan as CEO

Jan 6, 2025

04:43 PM EST, 01/06/2025 (MT Newswires) -- Helios Technologies ( HLIO ) said Monday its board promoted Sean P. Bagan as chief executive, effective immediately. Bagan was serving as interim CEO and CFO since July 8, 2024, according to the company. Bagan will continue to work as CFO and Helios is now starting search to backfill his previous role, the...

AbbVie cuts 2024 profit forecast on acquisition expenses

Jan 6, 2025

Jan 6 (Reuters) - AbbVie ( ABBV ) lowered its 2024 adjusted profit forecast on Monday as the drugmaker incurred $1.6 billion in acquisition expenses related to milestone payments as well as research-and-development costs. The company has been focusing on expanding its pipeline since its blockbuster arthritis drug, Humira, lost patent protection last year. To that end, AbbVie ( ABBV...

Couchbase Insider Sold Shares Worth $319,156, According to a Recent SEC Filing

Jan 6, 2025

04:44 PM EST, 01/06/2025 (MT Newswires) -- Margaret Chow, Senior Vice President & Chief Legal Officer, on January 02, 2025, sold 20,570 shares in Couchbase ( BASE ) for $319,156. Following the Form 4 filing with the SEC, Chow has control over a total of 148,321 shares of the company, with 148,321 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1845022/000186973925000002/xslF345X05/wk-form4_1736199512.xml ...